The nice people at Transfusion News sent their
update today. Zika virus, sickle cell… maybe it is a tad too “American”, but it is all good stuff…
 May 23, 2018Many patients with sickle cell disease (SCD) require chronic transfusions and are at risk for life-threatening delayed hemolytic transfusion reactions (DHTRs). The diagnosis of DHTR is often difficult because antibodies against the transfused RBCs are often undetectable and symptoms can mimic vaso-occlusive events. Presently, there are no existing guidelines or [Read More] |
 May 16, 2018Neutropenia is characterized by abnormally low counts of neutrophils and is a common condition among patients receiving chemotherapy or hematopoietic stem cell transplants. The RING study (Resolving Infection in Neutropenia with Granulocytes), sought to determine whether neutropenia patients infected with bacteria or fungi infections fared better with standard antimicrobial therapy [Read More] |
 May 10, 2018In 2015, the Zika virus (ZIKV) rapidly spread to the Americas and other countries, and four possible transfusion-transmission cases were documented in Brazil. In 2016, the US Food and Drug Administration (FDA) recommended ZIKV screening for all blood donations within the continental United States. The American Red Cross reports in [Read More] |
No comments:
Post a Comment